If what they hope comes true, this will go way higher than 25 cents. Overall, if everything pans out, IMUN will definitely jump up when contracts come out (I would think), but overall it's an outstanding growth stock anyway, so I really think it's just going to keep going up for years. They will continue to grow revenues, add countries, and work towards Phase 3 trials in US through Cytocom. They've already passed phase II for multiple diseases.
"Immune Therapeutics’ Goal is to Capture at Least 20% of Nigeria’s Addressable Billion Dollar Market for the Treatment of HIV/AIDS Within 12-18 Months with Lodonal, its Blockbuster Immunotherapy"
"
Immune Therapeutics On-Track to Achieve Profitability by End of 2017
“With Immune Therapeutics’ recently announced debt restructuring, the company is well positioned to move forward with its business plan, which calls for a significant ramp-up in revenues and achievement of profitability by the end of the fourth quarter. In addition to Nigeria, the company expects to obtain regulatory approvals in Kenya, Senegal, and Cote d’Ivoire by the fourth quarter of 2017 or early in 2018. We are very proud of the many achievements this company has made over the past several years and look forward to updating our shareholders in the coming weeks on our commercialization strategy followed by the announcement of initial contracts ,” concluded Ms. Griffin."
Commercialization strategy followed by announcement of initial contracts.
So it looks like the 2nd publishing from now will contain the contracts. Unless there's some form 4's in there.
Market Data 
Markets 
AI
